• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

用于靶向递送溶瘤麻疹病毒（OMV）疫苗株的制剂，以透明质酸包被的硫醇化壳聚糖作为治疗前列腺癌的绿色纳米制剂：一种病毒免疫治疗方法[撤回]

Formulation for the Targeted Delivery of a Vaccine Strain of Oncolytic Measles Virus (OMV) in Hyaluronic Acid Coated Thiolated Chitosan as a Green Nanoformulation for the Treatment of Prostate Cancer: A Viro-Immunotherapeutic Approach [Retraction].

出版信息

Int J Nanomedicine. 2024 Jun 12;19:5719-5720. doi: 10.2147/IJN.S482137. eCollection 2024.

DOI:10.2147/IJN.S482137
PMID:38895151
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11182757/
Abstract

[This retracts the article DOI: 10.2147/IJN.S386560.].

摘要

[本文撤回文章DOI: 10.2147/IJN.S386560。]

相似文献

1
Formulation for the Targeted Delivery of a Vaccine Strain of Oncolytic Measles Virus (OMV) in Hyaluronic Acid Coated Thiolated Chitosan as a Green Nanoformulation for the Treatment of Prostate Cancer: A Viro-Immunotherapeutic Approach [Retraction].用于靶向递送溶瘤麻疹病毒（OMV）疫苗株的制剂，以透明质酸包被的硫醇化壳聚糖作为治疗前列腺癌的绿色纳米制剂：一种病毒免疫治疗方法[撤回]
Int J Nanomedicine. 2024 Jun 12;19:5719-5720. doi: 10.2147/IJN.S482137. eCollection 2024.
2
Formulation for the Targeted Delivery of a Vaccine Strain of Oncolytic Measles Virus (OMV) in Hyaluronic Acid Coated Thiolated Chitosan as a Green Nanoformulation for the Treatment of Prostate Cancer: A Viro-Immunotherapeutic Approach.基于透明质酸修饰巯基化壳聚糖的疫苗株麻疹病毒（OMV）靶向递释系统的构建及其作为一种绿色纳米制剂治疗前列腺癌的研究：一种病毒免疫治疗方法。
Int J Nanomedicine. 2023 Jan 9;18:185-205. doi: 10.2147/IJN.S386560. eCollection 2023.
3
Co-delivery of oncolytic virus and chemotherapeutic modality: Vincristine against prostate cancer treatment: A potent viro-chemotherapeutic approach.溶瘤病毒与化疗药物联合递呈：长春新碱治疗前列腺癌：一种有效的病毒-化学治疗方法。
J Med Virol. 2024 Jul;96(7):e29748. doi: 10.1002/jmv.29748.
4
CD44 targeted delivery of oncolytic Newcastle disease virus encapsulated in thiolated chitosan for sustained release in cervical cancer: a targeted immunotherapy approach.巯基化壳聚糖包载的靶向 CD44 的溶瘤新城疫病毒用于宫颈癌的持续释放：一种靶向免疫治疗方法。
Front Immunol. 2023 May 22;14:1175535. doi: 10.3389/fimmu.2023.1175535. eCollection 2023.
5
Green synthesis of hyaluronic acid coated, thiolated chitosan nanoparticles for CD44 targeted delivery and sustained release of Cisplatin in cervical carcinoma.用于宫颈癌中CD44靶向递送和顺铂缓释的透明质酸包被、硫醇化壳聚糖纳米颗粒的绿色合成
Front Pharmacol. 2023 Jan 12;13:1073004. doi: 10.3389/fphar.2022.1073004. eCollection 2022.
6
Thiolated Chitosan Nanoparticles as a Delivery System for Antisense Therapy: Evaluation against EGFR in T47D Breast Cancer Cells [Retraction].硫醇化壳聚糖纳米颗粒作为反义治疗的递送系统：针对T47D乳腺癌细胞中表皮生长因子受体的评估[撤回]
Int J Nanomedicine. 2022 Aug 11;17:3581-3582. doi: 10.2147/IJN.S385585. eCollection 2022.
7
Anticancer Analysis of CD44 Targeted Cyclosporine Loaded Thiolated Chitosan Nanoformulations for Sustained Release in Triple-Negative Breast Cancer [Retraction].用于三阴性乳腺癌持续释放的 CD44 靶向负载环孢素的硫醇化壳聚糖纳米制剂的抗癌分析 [撤回]
Int J Nanomedicine. 2024 Jun 11;19:5705-5706. doi: 10.2147/IJN.S482136. eCollection 2024.
8
Corrigendum: CD44 targeted delivery of oncolytic Newcastle disease virus encapsulated in thiolated chitosan for sustained release in cervical cancer: a targeted immunotherapy approach.勘误：靶向CD44递送包裹于硫醇化壳聚糖中的溶瘤新城疫病毒用于宫颈癌的持续释放：一种靶向免疫治疗方法。
Front Immunol. 2024 Mar 11;15:1391710. doi: 10.3389/fimmu.2024.1391710. eCollection 2024.
9
Proof-of-principle that a decoy virus protects oncolytic measles virus against neutralizing antibodies.诱饵病毒保护溶瘤麻疹病毒免受中和抗体作用的原理验证。
Oncolytic Virother. 2018 Apr 30;7:37-41. doi: 10.2147/OV.S150637. eCollection 2018.
10
Opportunities to debottleneck the downstream processing of the oncolytic measles virus.有机会消除溶瘤麻疹病毒下游处理的瓶颈。
Crit Rev Biotechnol. 2020 Mar;40(2):247-264. doi: 10.1080/07388551.2019.1709794. Epub 2020 Jan 9.